Cheapest Semaglutide in India: Price Comparison Across Major Brands

Cheapest Semaglutide in India: Price Comparison Across Major Brands

Semaglutide pricing in India changed sharply after multiple domestic launches in March 2026. That means the answer to “what is the cheapest semaglutide in India?” is no longer just Ozempic versus Rybelsus. There are now several newer Indian brands, different devices, and meaningful price differences depending on whether you need a starter dose, a maintenance dose, a vial, or a pen.

This guide gives you a practical snapshot of the market as of May 8, 2026. The goal is not to tell you which medicine to buy on price alone, but to help you understand the current price bands so you can have a better conversation with your clinician. Consult your healthcare provider before starting any medication.

Why semaglutide prices now vary so much in India

Semaglutide is a GLP-1 receptor agonist used in type 2 diabetes and, in some formulations, chronic weight management. In India, the market now includes:

• Originator brands such as Ozempic and Rybelsus from Novo Nordisk
• Newer Indian brands launched after patent expiry, including products from Dr. Reddy’s, Alkem, Glenmark, Sun Pharma, Zydus, and Lupin
• Different delivery formats, including oral tablets, disposable pens, reusable-pen cartridges, and multi-dose vials

That combination matters because the cheapest product at treatment initiation may not stay the cheapest once you move to higher doses.

Current semaglutide price ranges in India

1) Ozempic and Rybelsus remain among the costlier options

Based on current Tata 1mg listings reviewed on May 8, 2026:

• Ozempic 0.5 mg injection is listed at about ₹7,057 per pen on Tata 1mg
• Rybelsus 14 mg tablets are listed at about ₹3,273 for 10 tablets on Tata 1mg, which works out to roughly ₹9,800 per month for a 30-day supply

That keeps the original Novo Nordisk brands well above most of the new Indian injectable launches on a monthly cost basis.

2) Glenmark’s GLIPIQ appears to be the cheapest official entry-point

Glenmark said at launch on March 21, 2026 that GLIPIQ would cost about ₹325 to ₹440 per week depending on vial strength. That makes it one of the lowest officially announced entry prices for semaglutide in India.

This is especially important for patients who are just starting treatment and need lower titration doses, where cost often becomes the biggest barrier.

3) Alkem’s semaglutide brands are also aggressively priced

Alkem announced on March 21, 2026 that its semaglutide injection brands Semasize, Obesema, and Hepaglide would start at ₹450 per week, or ₹1,800 for a month’s dosage for the disposable pen.

Current Tata 1mg examples support that lower-price positioning:

• Semasize 1 mg listing: about ₹1,350
• Obesema 0.25 mg listing: about ₹1,641

Real checkout prices can change by city, stock, and discounts, but these are still far below typical Ozempic pricing.

4) Dr. Reddy’s Obeda sits in the middle of the new market

Dr. Reddy’s announced on March 21, 2026 that Obeda would cost ₹4,200 per month for both its 2 mg and 4 mg pens. That is meaningfully cheaper than Ozempic, but usually not as cheap as the lowest-priced Glenmark or Alkem entry options.

5) Sun Pharma’s semaglutide brands span a wider price band

Sun Pharma said at launch on March 21, 2026 that:

• Noveltreat would cost about ₹900 to ₹2,000 per week
• Sematrinity would cost about ₹750 to ₹1,300 per week

These are still below many originator-brand price points, but they are not the cheapest options in the current Indian market.

6) Zydus and Lupin broaden access through reusable-pen brands

Zydus launched Semaglyn, Mashema, and Alterme, while Lupin co-markets the same semaglutide platform as Semanext and Livarise. Their main differentiator is the reusable-pen cartridge approach rather than a publicly highlighted lowest weekly launch price in the same way as Glenmark or Alkem.

In practice, these brands may make more sense for some patients because device design, dose convenience, and ongoing refill cost can matter just as much as the entry sticker price.

So what is the cheapest semaglutide in India right now?

If you mean the lowest officially announced starting cost, the current answer appears to be:

• GLIPIQ (Glenmark) at about ₹325 to ₹440 per week for vial-based therapy

If you mean the cheapest widely promoted pen-based starting option, then:

• Alkem’s semaglutide brands appear among the lowest, starting at about ₹450 per week

If you are comparing against the older well-known brands:

• Ozempic is usually much more expensive
• Rybelsus remains costly on a monthly basis because it is taken daily

Why the “cheapest” option is not always the best option

Price matters, but it should not be the only deciding factor. A lower-cost product may still differ in:

• indication (type 2 diabetes versus chronic weight management)
• device type (vial, disposable pen, reusable pen, oral tablet)
• dose escalation pathway
• stock availability in your city
• comfort with self-injection
• clinician familiarity with that brand

There is also a safety issue: semaglutide should only be used with a valid prescription and under medical supervision. Buying from informal sellers or unverified online channels may expose you to counterfeit or improperly stored products.

A simple way to think about affordability

A practical way to compare semaglutide options in India is:

1. Ask your doctor which molecule and indication fit your case
2. Check whether you need diabetes dosing or obesity dosing
3. Compare the full monthly cost at your likely dose, not just the starting dose
4. Confirm which brands are actually available at reputable pharmacies near you
5. Factor in the device you are most likely to use consistently

Sometimes the cheapest starting option is not the cheapest long-term option after titration.

Bottom line

As of May 8, 2026, semaglutide in India is no longer a two-brand market. The cheapest official starting prices now appear to come from Glenmark’s GLIPIQ and Alkem’s semaglutide brands, while Ozempic and Rybelsus generally remain more expensive.

Still, the right choice is not just the cheapest one. It is the product your clinician thinks is appropriate, that you can access reliably, and that you can use safely and consistently. Consult your healthcare provider before starting any medication.

Sources

1. Tata 1mg semaglutide brands page: https://www.1mg.com/generics/semaglutide-509803
2. Tata 1mg Ozempic 0.5 mg listing: https://www.1mg.com/drugs/ozempic-0.5mg-injection-1043336
3. Tata 1mg Rybelsus 14 mg listing: https://www.1mg.com/drugs/rybelsus-14mg-tablet-720022
4. Glenmark Pharmaceuticals launch release, March 21, 2026: https://glenmarkpharma.com/gpl_pdfs/media/PR_Glenmark%20Pharmaceuticals%20launches%20GLIPIQ%E2%93%87.pdf
5. Alkem press release, March 21, 2026: https://admin.alkemlabs.com/uploads/Press_Release_Alkem_Semaglutide_Day_1_launch_final_fc1e90e3be.pdf
6. Dr. Reddy’s press release, March 21, 2026: https://www.drreddys.com/cms/sites/default/files/2026-03/finalpressrelease-Dr.Reddy%27sSemalaunch-21stMarch2026.pdf
7. Sun Pharma press release, March 21, 2026: https://sunpharma.com/wp-content/uploads/2026/03/SEintimationPRforSemaglutide.pdf
8. Zydus Lifesciences semaglutide launch update, February 25, 2026: https://www.zyduslife.com/investor/admin/uploads/21/83/Zydus-plans-to-launch-innovative-Semaglutide-Injection-in-India-on-Day-1-of-patent-expiry--expanding-patient-access-to-GLP-1-therapy.pdf